Abstract
Abstract
Background
Immense attention has been given to the outcome of COVID-19 infection. However, comprehensive studies based on large populational cohort with long-term follow-up are still lacking. This study aimed to investigate the risk of various short-term comorbidities (within one month) and long-term sequelae (above one month) after COVID-19 infection.
Methods
In this large prospective cohort study with 14 months follow-up information based on UK biobank, we included 16,776 COVID-19-positive participants and 58,281 COVID-19-negative participants matched for comparison. The risk of each comorbidity and sequela was evaluated by multivariable logistic regression analysis and presented as hazard ratio (HR) and 95% confidence interval (95% CI).
Results
COVID-19-positive individuals had a higher risk of 47 types of comorbidities within one month following COVID-19 infection, especially those who were older, male, overweight/obese, ever-smoked, with more pre-existing comorbidities and hospitalized. About 70.37% of COVID-19 patients with comorbidities had more than one co-occurring comorbidities. Additionally, only 6 high-risk sequelae were observed after one month of COVID-19 infection, and the incidence was relatively low (< 1%).
Conclusion
In addition to long-term sequelae following COVID-19 infection, plenty of comorbidities were observed, especially in patients with older age, male gender, overweight/obese, more pre-existing comorbidities and severe COVID-19, indicating that more attention should be given to these susceptible persons within this period.
Funder
West China Hospital, Sichuan University
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Coronavirus disease (COVID-19) weekly epidemiological updates and monthly operational updates. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 7 Dec 2022.
2. Lee S-H, Yeoh ZX, Sachlin ISA, et al. Self-reported symptom study of COVID-19 chemosensory dysfunction in Malaysia. Sci Rep. 2022;12(1):2111. https://doi.org/10.1038/s41598-022-06029-6.
3. Lassen MCH, Skaarup KG, Lind JN, et al. Recovery of cardiac function following COVID-19—ECHOVID-19: a prospective longitudinal cohort study. Eur J Heart Fail. 2021;23(11):1903–12. https://doi.org/10.1002/ejhf.2347.
4. Robey RC, Kemp K, Hayton P, et al. Pulmonary sequelae at 4 months after COVID-19 infection: a single-centre experience of a COVID follow-up service. Adv Ther. 2021;38(8):4505–19. https://doi.org/10.1007/s12325-021-01833-4.
5. Prabhu M, Cagino K, Matthews KC, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020;127(12):1548–56. https://doi.org/10.1111/1471-0528.16403.